Bad Obama again: protecting industry profits at consumer expense
From the Center for American Progress:
"Pressed by industry lobbyists, White House officials on Wednesday assured drug makers that the administration stood by a behind-the-scenes deal to block any Congressional effort to extract cost savings from them beyond an agreed-upon $80 billion." The commitment may "irk some of the administration’s Congressional allies who have an eye on drug companies’ profits as" a way to pay for reform.
